384 related articles for article (PubMed ID: 16682145)
1. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
[TBL] [Abstract][Full Text] [Related]
3. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
[TBL] [Abstract][Full Text] [Related]
5. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of high-dose three-dimensional conformal radiotherapy and conventional radiotherapy for non-small-cell lung cancer.
Xu SJ; Shi YS; Song HC; Chen LH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):937-8. PubMed ID: 12377626
[TBL] [Abstract][Full Text] [Related]
7. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.
St Clair WH; Adams JA; Bues M; Fullerton BC; La Shell S; Kooy HM; Loeffler JS; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):727-34. PubMed ID: 14967427
[TBL] [Abstract][Full Text] [Related]
8. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer.
Narayan S; Henning GT; Ten Haken RK; Sullivan MA; Martel MK; Hayman JA
Lung Cancer; 2004 Apr; 44(1):79-88. PubMed ID: 15013586
[TBL] [Abstract][Full Text] [Related]
9. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?
Matney J; Park PC; Bluett J; Chen YP; Liu W; Court LE; Liao Z; Li H; Mohan R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):576-82. PubMed ID: 24074932
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.
Kesarwala AH; Ko CJ; Ning H; Xanthopoulos E; Haglund KE; O'Meara WP; Simone CB; Rengan R
Clin Lung Cancer; 2015 May; 16(3):237-44. PubMed ID: 25604729
[TBL] [Abstract][Full Text] [Related]
11. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
Register SP; Zhang X; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1015-22. PubMed ID: 20615629
[TBL] [Abstract][Full Text] [Related]
12. An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer.
Berman AT; Teo BK; Dolney D; Swisher-McClure S; Shahnazi K; Both S; Rengan R
Radiat Oncol; 2013 Jun; 8():144. PubMed ID: 23767810
[TBL] [Abstract][Full Text] [Related]
13. Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: effects on therapeutic ratio.
De Gersem WR; Derycke S; De Wagter C; De Neve WC
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):255-60. PubMed ID: 10758332
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of forward and inverse radiotherapy planning using Helax-TMS (version 6.0) for lung cancer patients treated with RTOG 93-11 dose-escalation protocol.
Underwood LJ; Murray BR; Robinson DM; Field GC; Roa WH
Med Dosim; 2003; 28(3):167-70. PubMed ID: 14563435
[TBL] [Abstract][Full Text] [Related]
15. An isotoxic planning comparison study for stage II-III non-small cell lung cancer: is intensity-modulated radiotherapy the answer?
Warren M; Webster G; Ryder D; Rowbottom C; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):461-7. PubMed ID: 24793504
[TBL] [Abstract][Full Text] [Related]
16. [The state of the art: radiation therapy for non-small cell lung cancer].
Chatani M
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():373-8. PubMed ID: 9369910
[TBL] [Abstract][Full Text] [Related]
17. Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?
McGibney C; Holmberg O; McClean B; Williams C; McCrea P; Sutton P; Armstrong J
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):339-50. PubMed ID: 10487554
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.
Wurstbauer K; Deutschmann H; Kranzinger M; Merz F; Rahim H; Sedlmayer F; Kogelnik HD
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):333-41. PubMed ID: 10760428
[TBL] [Abstract][Full Text] [Related]
19. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
Cozzi L; Fogliata A; Lomax A; Bolsi A
Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
[TBL] [Abstract][Full Text] [Related]
20. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
Bradley JD; Ieumwananonthachai N; Purdy JA; Wasserman TH; Lockett MA; Graham MV; Perez CA
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):49-57. PubMed ID: 11777621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
